-
Tytuł:
-
A novel personalized approach to cardiovascular prevention: The VIVOPTIM programme.
-
Autorzy:
-
Blacher J; Paris-Descartes University, AP-HP, Diagnosis and Therapeutic Center, Hôtel-Dieu University Hospital, Paris, France. Electronic address: .
Femery V; VYV Group, Paris, France.
Thorez F; Paris, France.
Sosner P; Paris-Descartes University, AP-HP, Diagnosis and Therapeutic Center, Hôtel-Dieu University Hospital, Paris, France; Sport Medicine Centre 'Mon Stade', Paris, France; Laboratory MOVE (EA 6314), Faculty of Sport Sciences, University of Poitiers, Poitiers, France.
Dibie A; Cardiology Department, Institut Mutualiste Montsouris, Paris, France.
Pavy B; Department of Cardiovascular Rehabilitation, Loire Vendée Océan hospital, Machecoul, France.
Beaunier P; Paris, France.
Chabot JM; HAS Santé, Saint-Denis, France.
Benzaqui M; Fédération nationale des établissements d'hospitalisation à domicile (FNEHAD), Paris, France.
Ohannessian R; Télémédecine 360, TLM 360, Paris, France.
Garnier M; Network Santé+, Paris, France.
Dubois A; Mutuelle générale de l'éducation nationale (MGEN), Paris, France.
Isnard-Bagnis C; Sorbonne University, AP-HP, Nephrology department, Pitié-Salpétrière University Hospital, Paris, France.
Durand-Zaleski I; Paris 12 University, AP-HP, Department of Public Health, Henri-Mondor University Hospital, Créteil, France.
-
Źródło:
-
Archives of cardiovascular diseases [Arch Cardiovasc Dis] 2020 Oct; Vol. 113 (10), pp. 590-598. Date of Electronic Publication: 2020 Oct 01.
-
Typ publikacji:
-
Journal Article
-
Język:
-
English
-
Imprint Name(s):
-
Original Publication: Amsterdam ; Boston : Elsevier Masson
-
MeSH Terms:
-
Healthy Lifestyle*
Patient Education as Topic*
Primary Prevention*
Telemedicine*
Cardiovascular Diseases/*prevention & control
Adult ; Aged ; Blood Pressure ; Cardiovascular Diseases/diagnosis ; Cardiovascular Diseases/etiology ; Diet, Healthy ; Exercise ; Female ; France ; Health Knowledge, Attitudes, Practice ; Health Status ; Humans ; Male ; Medication Adherence ; Middle Aged ; Pilot Projects ; Program Evaluation ; Risk Assessment ; Risk Factors ; Smoking Cessation ; Weight Loss
-
Contributed Indexing:
-
Keywords: Blood pressure; Poids; Pression artérielle; Prevention; Prévention; Smoking; Tabagisme; Weight
-
Entry Date(s):
-
Date Created: 20201004 Date Completed: 20201110 Latest Revision: 20201110
-
Update Code:
-
20240105
-
DOI:
-
10.1016/j.acvd.2020.02.005
-
PMID:
-
33011157
-
Background: Cardiovascular diseases are a leading cause of mortality, but a substantial proportion are preventable.
Aims: The Mutuelle générale de l'éducation nationale (MGEN), a provider of private health insurance in France, has developed the VIVOPTIM programme, a novel digital approach to healthcare based on individualized, multiprofessional, ranked management of cardiovascular risk factors.
Methods: Between November 2015 and June 2016, eligible individuals (age 30-70 years) from two regions of France were invited to participate. Volunteers completed a questionnaire based on the Framingham Heart Study Risk Score and were assigned to one of three cardiovascular risk levels. VIVOPTIM comprises four components: cardiovascular risk assessment, instruction on cardiovascular diseases and associated risk factors, personalized coaching (telephone sessions with a specially trained healthcare professional to provide information on risk factors and disease management, set individual health targets, monitor progress and motivate participants), and e-Health monitoring.
Results: Data from 2240 participants were analysed. Significant benefits were observed on mean systolic blood pressure (-3.4mmHg), weight (-1.5kg), smoking (-2.2 cigarettes/day) and daily steps (+1726 steps/day (all P<0.0001)), though not on weekly duration of exercise (-0.2hours/week, P=0.619).
Conclusion: As a result of the positive mid-to-long-term results of the pilot programme on weight, smoking, blood pressure, and uptake of physical activity, the VIVOPTIM programme was extend to the whole of France in 2018 and has the potential to have a genuine impact on patient care and organization of the healthcare system in France.
(Copyright © 2020. Published by Elsevier Masson SAS.)
